StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > StageZero is making lots of money with COVID testing

<< Previous

Bullboard Posts

Next >>

Comment by MarketMoneyon Mar 30, 2021 9:14am

170 Views

Post# 32904836

RE:RE:RE:RE:RE:StageZero is making lots of money with COVID testing

Just imagine all the people who bought GME at 4USD and sold after the breakouts at 7USD while on a weekly stage 2....yes they made $$$$ but if they keot their shares and sold a few months later at 400USD per say they would had made 100x their initial investment!

Fundamentals would have sold at 7USD and technical traders would have sold above 300USD :-)

<< Previous

Bullboard Posts

Next >>

Canada orders national security review over Paladin-Fission deal